分子 | 货号 | host | 产品描述 | 结构 |
---|---|---|---|---|
VEGF165 | GMP-VE5H23 | HEK293 | GMP Human VEGF165 ProteinHOT | |
VEGF165 | VE5-H4210 | HEK293 | Human VEGF165 Protein, premium gradeHOT | |
VEGF165 | VE5-H5248 | HEK293 | Human VEGF165 Protein, His TagHOT | |
VEGF165 | VE5-H8210 | HEK293 | Biotinylated Human VEGF165 Protein, epitope tag free, ultra sensitivity, primary amine labelingHOT | |
VEGF165 | VE5-H82Q0 | HEK293 | Biotinylated Human VEGF165 Protein, His,HOT | |
VEGF165 | VE5-HF248 | HEK293 | FITC-Labeled Human VEGF165 Protein, His TagHOT | |
VEGF121 | VE1-H4213 | HEK293 | Human VEGF121 Protein, premium gradeHOT | |
VEGF121 | VE1-H5246 | HEK293 | Human VEGF121 Protein, His Tag (MALS verified)HOT | |
VEGF121 | VE1-H82E7 | HEK293 | Biotinylated Human VEGF121 Protein, ,His TagHOT | |
VEGF110 | VE0-H5212 | HEK293 | Human VEGF110 Protein, premium grade | |
VEGF110 | VE0-H52H3 | HEK293 | Human VEGF110 Protein, His Tag (MALS verified) | |
VEGF120 | VE0-M4211 | HEK293 | Mouse VEGF120 Protein, Tag Free | |
VEGF120 | VE0-M82Q2 | HEK293 | Biotinylated Mouse VEGF120 Protein, His, | |
VEGF164 | VE4-M4216 | HEK293 | Mouse VEGF164 Protein, Tag Free (HPLC-verified) | |
VEGF164 | VE4-M82Q3 | HEK293 | Biotinylated Mouse VEGF164 Protein, His, | |
VEGF165 | EP-137 | - | VEGFA : VEGFR2 [Biotinylated] Inhibitor Screening ELISA KitHOT | |
VEGF165 | MBS-K036 | - | Human VEGF165-coupled Magnetic BeadsHOT |
分子 | 货号 | host | 产品描述 | 结构 |
---|---|---|---|---|
VEGF R1 | VE1-H5253 | HEK293 | Human VEGF R1 Protein, Fc Tag | |
VEGF R1 | VE1-H52H9 | HEK293 | Human VEGF R1 / Flt-1 Protein, His Tag (MALS verified) | |
VEGF R1 | VE1-H82E3 | HEK293 | Biotinylated Human VEGF R1 / Flt-1 Protein, His, | |
VEGF R1 | VE1-M5256 | HEK293 | Mouse VEGF R1 / Flt-1 Protein, Mouse IgG2a Fc Tag, low endotoxin |
分子 | 货号 | host | 产品描述 | 结构 |
---|---|---|---|---|
VEGF R2 | KDR-H5227 | HEK293 | Human VEGF R2 / KDR Protein, His Tag (MALS verified) | |
VEGF R2 | KDR-H5280 | HEK293 | Human VEGF R2 / KDR Protein, Twin-Strep Tag (MALS verified) | |
VEGF R2 | KDR-H82E5 | HEK293 | Biotinylated Human VEGF R2 / KDR Protein, ,His Tag | |
VEGF R2 | KDR-HP227 | HEK293 | PE-Labeled Human VEGF R2 / KDR Protein, His Tag (Site-specific conjugation) | |
VEGF R2 | VE2-C52H3 | HEK293 | Rhesus macaque VEGF R2 / KDR Protein, His Tag | |
VEGF R2 | VE2-H5255 | HEK293 | Human VEGF R2 / KDR Protein, Fc Tag (MALS verified) | |
VEGF R2 | VE2-HA224 | HEK293 | APC-Labeled Human VEGF R2 / KDR Protein, His Tag (Site-specific conjugation) | |
VEGF R2 | VE2-HF254 | HEK293 | FITC-Labeled Human VEGF R2 / KDR Protein, His Tag | |
VEGF R2 | VE2-M5258 | HEK293 | Mouse VEGF R2 / KDR Protein, Mouse IgG2a Fc Tag, low endotoxin |
>>>如果您希望ACRO开发更多类型的VEGF的产品或者有定制化需求,请点此 联系我们。
>>> 了解更多热门双特异性抗体热门靶点
Immobilized Human VEGF R1&VEGF R2, Fc Tag at 2 μg/mL (100 μL/well) can bind Human VEGF165, His Tag (Cat. No. VE5-H5248) with a linear range of 0.004-0.063 μg/mL (QC tested).
Protocol
Immobilized Biotinylated Human VEGF165, His,Avitag (Cat. No. VE5-H82Q0) on CM5 Chip via Streptavidin, can bind Avastin with an affinity constant of 0.417 nM as determined in SPR assay (Biacore T200) (Routinely tested).
Protocol
Loaded Avastin (Bevacizumab) on AHC Biosensor, can bind Human VEGF165, His Tag (Cat. No. VE5-H5248) with an affinity constant of 0.448 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Protocol
ActiveMax® Human VEGF165, Tag Free (MALS verified) (Cat. No. VE5-H4210) stimulates proliferation of human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is 4.216-9.281 ng/mL (Routinely tested).
Protocol
Inhibition assay shows that the proliferation effect of ActiveMax® Human VEGF165, Tag Free (MALS verified) (Cat. No. VE5-H4210) is inhibited by increasing concentration of anti-VEGF mAb (Avastin). The concentration of VEGF165 used is 20 ng/mL. The ED50 is 0.065-0.229 μg/mL (Routinely tested).
Protocol
CHLOROTOXIN AGENTS AND USES THEREOF
Authors: Mcgonigle Sharon,Majumder Utpal,Postema Maarten H. D.
Cited Product: VE5-H4210
Journal: US20200206312A1 2020
Application: Binding Assay
CHLOROTOXIN AGENTS AND USES THEREOF
Authors: Mcgonigle Sharon,Majumder Utpal,Postema Maarten H. D.
Cited Product: VE5-H8210
Journal: US20200206312A1 2020
Application: Binding Assay
FGF primes angioblast formation by inducing ETV2 and LMO2 via FGFR1/BRAF/MEK/ERK
Authors: Chen PC, Hsueh YW, Lee YH, et al.
Cited Product: VE5-H4210
Journal: Cell Mol Life Sci 2020
Application: Flow cytometry
Authors: Meng Wang, Youke Qi, Yongning Sun
Cited Product: VE5-H5248
Journal: BioMed Research International 2020
Application: SPR
Biophysical characterization platform informs protein scaffold evolvability
Authors: Golinski AW, et al
Cited Product: VE1-H82E7
Journal: ACS COMB SCI 2019
Application: Binding Assay
Authors: F Corti, et al
Cited Product: VE5-H8210
Journal: Nat Commun 2019
Application: ELISA
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Authors: McGonigle S, et al
Cited Product: VE5-H8210
Journal: Cell Commun Signal 2019
Application: BLI
Methods of producing glycosylated proteins
Authors: ML Wetter, et al
Cited Product: VE5-H4210
Journal: US20180354997A1 2018
Application: SPR
Neuropilin-1 mediates Neutrophil Elastase uptake and cross-presentation in breast cancer cells
Authors: Kerros C, et al.
Cited Product: VE5-H5248
Journal: J Biol Chem 2017
Application: BLI
A biosynthetic route for polysialylating proteins in Escherichia coli
Authors: Keys TG, et al.
Cited Product: VE5-H4210
Journal: Metab Eng 2017
Application: SPR
In vitro Fab display: a cell-free system for IgG discovery
Authors: Stafford RL, et al.
Cited Product: VE1-H4213
Journal: Protein Eng Des Sel 2014
Application: SPR(Biacore T200)